Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Curt W Burger

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
Plos One|August 1, 2012
Identification of quiescent, stem-like cells in the distal female reproductive tractYongyi Wang, Andrea Sacchetti, Matthijs R van Dijk, et al.
Molecular Endocrinology (Baltimore, Md.)|April 29, 2006
Ligand-controlled interaction of histone acetyltransferase binding to ORC-1 (HBO1) with the N-terminal transactivating domain of progesterone receptor induces steroid receptor coactivator 1-dependent coactivation of transcriptionMaria Georgiakaki, Nathalie Chabbert-Buffet, Boris Dasen, et al.
Plos One|February 2, 2012
Progesterone inhibits epithelial-to-mesenchymal transition in endometrial cancerPaul H van der Horst, Yongyi Wang, Ingrid Vandenput, et al.
Fertility and Sterility|July 11, 2006
Histological and immunohistochemical evaluation of postmenopausal endometrium after 3 weeks of treatment with tibolone, estrogen only, or estrogen plus progestagenAnet H A Klaassens, F Heidy van Wijk, Payman Hanifi-Moghaddam, et al.
International Journal of Cancer|May 24, 2008
Reduced local immunity in HPV-related VIN: expression of chemokines and involvement of immunocompetent cellsLindy A M Santegoets, Manon van Seters, Claudia Heijmans-Antonissen, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|November 15, 2007
Genomic and nongenomic effects of estrogen signaling in human endometrial cells: involvement of the growth factor receptor signaling downstream AKT pathwaySussane C J P Gielen, Lindy A M Santegoets, Liesbeth C M Kühne, et al.
International Journal of Cancer|January 30, 2014
A mouse model for endometrioid ovarian cancer arising from the distal oviductPaul H van der Horst, Marten van der Zee, Claudia Heijmans-Antonissen, et al.
Journal of Lower Genital Tract Disease|May 6, 2024
Outcome Measures in Adult Vulvar Lichen Sclerosus: A Case Series of Women Diagnosed as JuvenilesBeth Morrel, Marianne J Ten Kate-Booij, Charlotte van Dijk, et al.
Cancer|November 21, 2012
The risk of primary and contralateral breast cancer after ovarian cancer in BRCA1/BRCA2 mutation carriers: Implications for counselingPeggy M L H Vencken, Mieke Kriege, Maartje Hooning, et al.
Human Reproduction (Oxford, England)|December 14, 2007
Difference in signalling between various hormone therapies in endometrium, myometrium and upper part of the vaginaPayman Hanifi-Moghaddam, Bianca Boers-Sijmons, Anet H A Klaassens, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Plos One|August 1, 2012
Identification of quiescent, stem-like cells in the distal female reproductive tractYongyi Wang, Andrea Sacchetti, Matthijs R van Dijk, et al.
Molecular Endocrinology (Baltimore, Md.)|April 29, 2006
Ligand-controlled interaction of histone acetyltransferase binding to ORC-1 (HBO1) with the N-terminal transactivating domain of progesterone receptor induces steroid receptor coactivator 1-dependent coactivation of transcriptionMaria Georgiakaki, Nathalie Chabbert-Buffet, Boris Dasen, et al.
Plos One|February 2, 2012
Progesterone inhibits epithelial-to-mesenchymal transition in endometrial cancerPaul H van der Horst, Yongyi Wang, Ingrid Vandenput, et al.
Fertility and Sterility|July 11, 2006
Histological and immunohistochemical evaluation of postmenopausal endometrium after 3 weeks of treatment with tibolone, estrogen only, or estrogen plus progestagenAnet H A Klaassens, F Heidy van Wijk, Payman Hanifi-Moghaddam, et al.
International Journal of Cancer|May 24, 2008
Reduced local immunity in HPV-related VIN: expression of chemokines and involvement of immunocompetent cellsLindy A M Santegoets, Manon van Seters, Claudia Heijmans-Antonissen, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|November 15, 2007
Genomic and nongenomic effects of estrogen signaling in human endometrial cells: involvement of the growth factor receptor signaling downstream AKT pathwaySussane C J P Gielen, Lindy A M Santegoets, Liesbeth C M Kühne, et al.
International Journal of Cancer|January 30, 2014
A mouse model for endometrioid ovarian cancer arising from the distal oviductPaul H van der Horst, Marten van der Zee, Claudia Heijmans-Antonissen, et al.
Journal of Lower Genital Tract Disease|May 6, 2024
Outcome Measures in Adult Vulvar Lichen Sclerosus: A Case Series of Women Diagnosed as JuvenilesBeth Morrel, Marianne J Ten Kate-Booij, Charlotte van Dijk, et al.
Cancer|November 21, 2012
The risk of primary and contralateral breast cancer after ovarian cancer in BRCA1/BRCA2 mutation carriers: Implications for counselingPeggy M L H Vencken, Mieke Kriege, Maartje Hooning, et al.
Human Reproduction (Oxford, England)|December 14, 2007
Difference in signalling between various hormone therapies in endometrium, myometrium and upper part of the vaginaPayman Hanifi-Moghaddam, Bianca Boers-Sijmons, Anet H A Klaassens, et al.
Pageof 8